Clinical Trial Update: The Combination of Anti-PD-1 With Radiotherapy in Previously Untreated Metastatic Melanoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating the combination of anti-PD-1 therapy with radiotherapy in previously untreated metastatic melanoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Anti-PD-1

Snippet

Sponsor: Yonsei University | Conditions: Melanoma | Phase 2 | Status: UNKNOWN